Prelude Therapeutics
PRLD
#8532
Rank
A$0.39 B
Marketcap
A$4.88
Share price
-0.77%
Change (1 day)
88.72%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2026 (TTM): A-$1.41

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.42. In 2025 the company made an earnings per share (EPS) of A-$1.95 an increase over its 2024 EPS that were of A-$2.54.

EPS history for Prelude Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.41-27.81%
2025A-$1.95-23.21%
2024A-$2.54-16.83%
2023A-$3.05-17.21%
2022A-$3.690.41%
2021A-$3.67-46.71%
2020A-$6.89435.92%
2019A-$1.2986.09%
2018A-$0.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04 43.62%๐Ÿ‡บ๐Ÿ‡ธ USA